Show 1412: Beyond Amyloid: The Science That Could Change the Course of Alzheimer Disease (Archive)
About this episode
The episode discusses new FDA-approved pharmaceuticals for Alzheimer disease and questions the focus on amyloid plaques in treatment.
This week, we look at the new pharmaceuticals that the FDA has approved for treating Alzheimer disease. Although they are effective at removing amyloid plaques from the brain, they don’t seem to help patients function better. Is it time to turn away from an exclusive focus on amyloid to consider other factors that might affect cognitive decline and change the course of Alzheimer disease? At The People’s Pharmacy, we strive to bring you up to date, rigorously researched insights and conversations about health, medicine, wellness and health policies and health systems. While these conversations intend to offer insight and perspective, the content is provided solely for informational and educational purposes. Please consult your healthcare provider before making any changes to your medical care or treatment. How You Can Listen You could listen through your local public radio station or get the live stream at 7 am EDT on your computer or smart phone ( wunc.org ). Here is a link so you can find which stations carry our broadcast. If you can’t listen to the broadcast, you may wish to hear the podcast later. You can subscribe through your favorite podcast provider, download the mp3…
More episodes of The People's Pharmacy
- Show 1480: The Sleep Reset: How to Fall Asleep and Stay Asleep
- Show 1479: Must You Shun the Sun to Save Your Skin?
- Show 1478: The Outdoor Prescription for Fighting Dementia, Depression and Heart Disease
- Show 1477: Answering Your Questions About Vision Problems
- Show 1476: Tell Me Where It Hurts: A Roadmap for Managing Chronic Pain
- Show 1446: The Science of Strong Bones: Lifestyle, Medication and Movement
Explore listener stats, chart rankings, contacts and more on the The People's Pharmacy podcast page.